Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), β blockers, and mineralocorticoid receptor antagonists (MRAs) are of proven benefit and are recommended by guidelines for management of patients with heart failure and reduced ejection fraction (HFrEF). We aim...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tiew‐Hwa Katherine Teng, Jasper Tromp, Wan Ting Tay, Inder S. Anand, Wouter Ouwerkerk, Vijay Chopra, Gurpreet Singh Wander, Jonathan JL Yap, Michael R. MacDonald, Chang Xu, Yvonne M.F. Chia, Wataru Shimizu, Mark Richards, Adriaan A. Voors, Carolyn S.P. Lam
Médium: Artigo
Jazyk:angličtina
Vydáno: 2018
On-line přístup:https://doi.org/10.1016/s2214-109x(18)30306-1
https://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(18)30306-1.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!